People

Andrew Miller

Andrew Miller serves as Board Chair at Progentos Therapeutics, a biotechnology company developing regenerative neuroscience medicines. Alto director appointed in May 2026. Founded Karuna Therapeutics and helped invent its schizophrenia treatment KarXT, now COBENFY, before its acquisition by Bristol Myers Squibb. He chairs Progentos and serves on Montara’s board, and holds chemical engineering degrees from MIT and Illinois.